Building a better approach to Alzheimer’s diagnosis
Guest editorial by Russ Lebovitz, MD, PhD, is CEO and Co-Founder of Amprion
Guest editorial by Russ Lebovitz, MD, PhD, is CEO and Co-Founder of Amprion
As Gram-negative resistance becomes more complex, laboratories and clinicians are working together to turn susceptibility data into more targeted treatment decisions
Delivering reduced hands-on time, more consistent results, and higher sample throughput
The non-invasive test could help clinicians identify women needing urgent hospital investigations while reassuring those unlikely to have womb cancer
The two companies aim to strengthen disease awareness, support earlier assessment of the disease, and remove barriers to non-invasive testing
IBMS Chief Executive David Wells shares valuable insights on workforce, automation, and sustainable transformation
Roche and Genentech have signed a 10-year lease for the 95,000 square metre center, which will have capacity for up to 500 people across research, clinical development, data science, and AI, to drive innovation in drug discovery and development
The first syndromic tests including MERS-CoV to achieve this certification
HistoCore LIGHTNING C Laser Cassette Printer helps laboratories improve specimen identification and tracking while reducing costs
Brazilian Health Regulatory Agency (ANVISA) has given market authorization for Lumipulse G NfL Blood and Lumipulse G pTau 217 Plasma
The same AI tools that are speeding up diagnosis in the clinical lab are also arming the people trying to break into it
This guest editorial features insights from Consultant Biomedical Scientist David Norcliffe, Advanced Clinical Practitioner David Manuel, and Bernie Benson, Founder of Benson Viscometers, on selecting inflammatory markers for clinical diagnostics
Complementary technologies deliver an integrated, end-to-end clinical flow cytometry workflow for laboratories across Europe
New partnership to create health innovation sandbox that will test promising new technologies and build evidence to accelerate the safe adoption of technologies, including AI, in the NHS
New synthetic cell-mimic controls enable researchers to achieve reproducible results across multiple sites and instruments
Comprehensive pharmacogenetic testing solution aligned with latest clinical guidance to support informed chemotherapy treatment decisions
As laboratories embrace digital pathology, one histology team discovered that improving workflow quality began with re-evaluating one of the most fundamental components of the entire process: the microscope slide
Although AI tools can support in capturing what was said by patients, they can sometimes miss out on important aspects of consultations
Clinical microbiology experts Dr. Stella Antonara, OhioHealth, and Dr. J. Kristie Johnson, University of Maryland Medical Center, share their experiences in this SelectScience interview
First and only FDA-cleared, single-biomarker blood test supporting both rule-in and rule-out assessment of amyloid pathology across primary and specialty care settings
Innovations aim to support earlier infectious disease detection through sensitive and efficient serology testing
Guest editorial by By Allyson Kozak, PhD, MBA, NRCC, senior scientific affairs manager for Mass Spectrometry and Women’s Health at Roche Diagnostics
As new HIV infections persist worldwide, experts say the fight against the virus increasingly hinges on getting diagnosis right in the laboratory
In collaboration with Siemens Healthineers, this advanced PET/CT technology helps expand access to cancer imaging closer to patients